Long-term dissemination of acquired AmpC β-lactamases among Klebsiella spp. and Escherichia coli in Portuguese clinical settings

Occurrence and molecular characterization of Klebsiella pneumoniae ST37 clinical isolates producing plasmid-mediated AmpC recovered over a 3-year period

(2012) Marina Illiaquer et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain

(2012) E. Miró et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Prevalence of plasmid-mediated AmpC β-lactamase-producing Escherichia coli and spread of the ST131 clone among extended-spectrum β-lactamase-producing E. coli in Japan

(2012) Yasufumi Matsumura et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Virulence Profiles of Bacteremic Extended-Spectrum β-Lactamase-Producing Escherichia coli: Association with Epidemiological and Clinical Features

(2012) Jesús Rodríguez-Baño et al.   PLoS One

Population Distribution of Beta-Lactamase Conferring Resistance to Third-Generation Cephalosporins in Human Clinical Enterobacteriaceae in The Netherlands

(2012) Guido M. Voets et al.   PLoS One

Evolution and Spread of a Multidrug-Resistant Proteus mirabilis Clone with Chromosomal AmpC-Type Cephalosporinases in Europe

(2011) M. M. D'Andrea et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prevalence and characterization of extended-spectrum β-lactamase– and AmpC β-lactamase–producing Escherichia coli: results of the CANWARD 2007–2009 study

(2011) Patricia J. Simner et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Plasmid typing and genetic context of AmpC β-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes: findings from a Spanish hospital 1999–2007

(2011) Caterina Mata et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Prevalence of SXT/R391-like integrative and conjugative elements carrying blaCMY-2 in Proteus mirabilis

(2011) Caterina Mata et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Escherichia coliSequence Type ST131 as the Major Cause of Serious Multidrug‐ResistantE. coliInfections in the United States

(2010) James R. Johnson et al.   CLINICAL INFECTIOUS DISEASES

CMY-2, CMY-8b, and DHA-1 plasmid-mediated AmpC β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from a university hospital, Thailand

(2010) Supoj Singtohin et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Epidemiology of Escherichia coli clinical isolates producing AmpC plasmidic β-lactamase during a 5-year period in a French teaching Hospital

(2010) Stéphane Corvec et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype

(2010) Rikke Lind Jørgensen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Major Differences Exist in Frequencies of Virulence Factors and Multidrug Resistance between Community and Nosocomial Escherichia coli Bloodstream Isolates

(2010) N. M. Cooke et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Laboratory Surveillance for Prospective Plasmid-Mediated AmpC  -Lactamases in the Kinki Region of Japan

(2010) K. Yamasaki et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Clinical Features and Molecular Epidemiology of CMY‐Type β‐Lactamase–ProducingEscherichia coli

(2009) Hanna E. Sidjabat et al.   CLINICAL INFECTIOUS DISEASES

Prevalence of acquired AmpC β-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes at a Spanish hospital from 1999 to 2007

(2009) C. Mata et al.   CLINICAL MICROBIOLOGY AND INFECTION

Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway

(2009) U. Naseer et al.   CLINICAL MICROBIOLOGY AND INFECTION

AmpC  -Lactamases

(2009) G. A. Jacoby   CLINICAL MICROBIOLOGY REVIEWS

Characterization of plasmids encoding CMY-2 AmpC β-lactamases from Escherichia coli in Canadian intensive care units

(2009) Patricia J. Baudry et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Prevalence of plasmid-mediated AmpC β-lactamases among Enterobacteriaceae in Algiers hospitals

(2009) Hassen Iabadene et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Nationwide survey of extended-spectrum β-lactamase-producing Enterobacteriaceae in the French community setting

(2009) C. Arpin et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum  -lactamase in clinical isolates of Escherichia coli from Korea

(2009) W. Song et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Antibiotic Resistance Mechanisms of Escherichia coli Isolates from Urinary Specimens

(2009) Sungwook Song et al.   Korean Journal of Laboratory Medicine

Molecular Epidemiology and Genetic Environment of Acquired blaACC-1 in Salmonella enterica Serotype Livingstone Causing a Large Nosocomial Outbreak in Tunisia

(2009) Sonia Ktari et al.   Microbial Drug Resistance

Detection and molecular characterisation of plasmidic AmpC β-lactamases in Klebsiella pneumoniae isolates from a tertiary-care hospital in Dublin, Ireland

(2008) C. Roche et al.   CLINICAL MICROBIOLOGY AND INFECTION

Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe

(2008) R. Cantón et al.   CLINICAL MICROBIOLOGY AND INFECTION

The prevalence of plasmid-mediated AmpC β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from five children’s hospitals in China

(2008) H. Ding et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Prevalence of Plasmid-Mediated AmpC  -Lactamases in a Chinese University Hospital from 2003 to 2005: First Report of CMY-2-Type AmpC  -Lactamase Resistance in China

(2008) Y. Li et al.   JOURNAL OF CLINICAL MICROBIOLOGY